D2NL34 fundamentals
An in-depth look to DENALI THERADRN operating, investing, and financing activities
D2NL34 free cash flow for Q2 24 is -538.45 M BRL. For 2023, D2NL34 free cash flow was -1.8 B BRL and operating cash flow was -1.74 B BRL.
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: BRL
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM